Aluminum does not enhance beta-amyloid toxicity in rat hippocampal cultures

Brain Research
Christiane M NdayBettina Platt

Abstract

A number of environmental factors have been implicated in neurodegenerative disorders, including metallotoxins such as aluminum (Al). In the present study, the toxicity of Al-quinate (AlQ), a well-characterized Al complex, was investigated in primary rat hippocampal cultures in comparison to inorganic Al (Al-S). AlQ was significantly less toxic than Al-S during both short- (3h) and long-term (24h) incubations. The neuroprotective properties of quinic acid (which constitutes the quinate moiety of AlQ) against short-term incubations with Al-S were subsequently assessed, and the organic compound was found to provide full protection, comparable to synthetic metal chelating agents desferrioxamine and clioquinol. Finally, potential synergistic actions between Al (AlQ and Al-S) and beta-amyloid (Abeta) were investigated. Neither Al form appeared to enhance Abeta toxicity, in fact, AlQ significantly reduced Abeta toxicity. Collectively, this study highlights further the impact of structural features and physiological ligands of metal complexes on toxicity profiles, and reveals promising properties of quinic acid as a metal chelator. Despite previous reports suggesting synergistic toxicity between Al and Abeta, we could not identify suc...Continue Reading

References

Dec 6, 1994·Proceedings of the National Academy of Sciences of the United States of America·A Lorenzo, B A Yankner
Apr 1, 1996·Biological & Pharmaceutical Bulletin·P BasnetT Namba
Jul 10, 1999·Neuroscience Letters·S C Bondy, A Truong
Jul 27, 2001·Brain Research Bulletin·B PlattZ Henderson
Aug 21, 2001·Biological & Pharmaceutical Bulletin·J Y HurS Y Kim
Feb 26, 2005·Science·Gorazd B StokinLawrence S B Goldstein
Mar 5, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Orly LazarovSangram S Sisodia
Jul 2, 2005·Cellular and Molecular Life Sciences : CMLS·F RicchelliP Zatta
Apr 22, 2006·Journal of Neurology, Neurosurgery, and Psychiatry·C Exley, M M Esiri
May 2, 2006·The Journal of Biological Chemistry·Anthony R WhiteColin L Masters
Feb 17, 2007·Neurotoxicology·Bettina PlattAthanasios Salifoglou
Dec 28, 2007·The International Journal of Biochemistry & Cell Biology·Gulay FilizAnthony R White
Jul 16, 2008·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Ashley I Bush, Rudolph E Tanzi
Aug 23, 2008·Journal of Pharmacological Sciences·Benjamin D DreverBettina Platt

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Forebrain- Circuits

Basal forebrain is a region in the brain important for production of acetylcholine and is the major cholinergic output of the CNS. Discover the latest research on circuits in the basal forebrain here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.